The Annual Meeting of the American College of Rheumatologists was held virtually November 3-10, 2021. Vanderbilt University Medical Center presenters included:
Jennifer Young-Glazer, M.D.
Jo-1-Binding and Clonally-Expanded Memory B Cells Express Germline and Somatically-Mutated B Cell Receptors in Anti-tRNA Synthetase Syndrome Patients
Jason Springer, M.D.
Pharmacological Response of Rituximab Based on Dose Intensity in Maintenance; Hot Topics in Research & New ACR/VF Guidelines – Part 2: Treatment of Large-vessel Vasculitis
Erin Wilfong, M.D.
High-Dimensional Analysis Reveals Abnormal B Cell Subsets Associated with Specific Changes to Circulating T and Myeloid Cell Populations in Patients with Idiopathic Inflammatory Myopathies; Pathophysiology of the Antifibrotic Pathway & Rationale for Drug Class in CTD-ILD; Rheumatology Intensivists: Managing Critical Illness in Autoimmune Disease
Tracy Frech, M.D.
Co-moderator – Plenary Session
Jeffrey Rathmell, Ph.D.
Metabolic Regulation of Immune Function; Overview of Immunometabolism
April Barnado, M.D.
Increased Adverse Maternal Postpartum Outcomes in Systemic Lupus Erythematosus Pregnancies Compared to Controls; Tuesday, Class V Systemic Lupus Erythematosus Nephritis Patients Are Undertreated and Face Similar Adverse Renal Outcomes as Class III/IV Patients
Douglas Johnson, M.D.
Outcomes and Disease Characteristics in Patients with Rheumatoid Arthritis Treated with Immune Checkpoint Inhibitors for Malignancy
Elizabeth Phillips, M.D.
Pediatrics – Still’s Disease, Lung Complications & Drug Hypersensitivity